133 related articles for article (PubMed ID: 28681104)
1. Benign breast disease and risk of thyroid cancer.
Luo J; Hendryx M; Nassir R; Cheng TD; Lane D; Margolis KL
Cancer Causes Control; 2017 Sep; 28(9):913-920. PubMed ID: 28681104
[TBL] [Abstract][Full Text] [Related]
2. A prospective study of endometriosis and risk of benign breast disease.
Farland LV; Tamimi RM; Eliassen AH; Spiegelman D; Collins LC; Schnitt SJ; Missmer SA
Breast Cancer Res Treat; 2016 Oct; 159(3):545-52. PubMed ID: 27604359
[TBL] [Abstract][Full Text] [Related]
3. Breast Density and Benign Breast Disease: Risk Assessment to Identify Women at High Risk of Breast Cancer.
Tice JA; Miglioretti DL; Li CS; Vachon CM; Gard CC; Kerlikowske K
J Clin Oncol; 2015 Oct; 33(28):3137-43. PubMed ID: 26282663
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for breast cancer development by tumor characteristics among women with benign breast disease.
Figueroa JD; Gierach GL; Duggan MA; Fan S; Pfeiffer RM; Wang Y; Falk RT; Loudig O; Abubakar M; Ginsberg M; Kimes TM; Richert-Boe K; Glass AG; Rohan TE
Breast Cancer Res; 2021 Mar; 23(1):34. PubMed ID: 33736682
[TBL] [Abstract][Full Text] [Related]
5. Association between lifestyle, menstrual/reproductive history, and histological factors and risk of breast cancer in women biopsied for benign breast disease.
Arthur R; Wang Y; Ye K; Glass AG; Ginsberg M; Loudig O; Rohan T
Breast Cancer Res Treat; 2017 Oct; 165(3):623-631. PubMed ID: 28643020
[TBL] [Abstract][Full Text] [Related]
6. Menstrual and reproductive history, postmenopausal hormone use, and risk of benign proliferative epithelial disorders of the breast: a cohort study.
Cui Y; Page DL; Lane DS; Rohan TE
Breast Cancer Res Treat; 2009 Mar; 114(1):113-20. PubMed ID: 18360772
[TBL] [Abstract][Full Text] [Related]
7. Benign Breast Disease, NSAIDs, and Postmenopausal Breast Cancer Risk in the CPS-II Cohort.
Sherman ME; Vierkant RA; Masters M; Radisky DC; Winham SJ; Degnim AC; Vachon CM; Patel AV; Teras LR
Cancer Prev Res (Phila); 2023 Mar; 16(3):175-184. PubMed ID: 36596665
[TBL] [Abstract][Full Text] [Related]
8. Benign breast disease increases breast cancer risk independent of underlying familial risk profile: Findings from a Prospective Family Study Cohort.
Zeinomar N; Phillips KA; Daly MB; Milne RL; Dite GS; MacInnis RJ; Liao Y; Kehm RD; Knight JA; Southey MC; Chung WK; Giles GG; McLachlan SA; Friedlander ML; Weideman PC; Glendon G; Nesci S; ; Andrulis IL; Buys SS; John EM; Hopper JL; Terry MB
Int J Cancer; 2019 Jul; 145(2):370-379. PubMed ID: 30725480
[TBL] [Abstract][Full Text] [Related]
9. A cohort study of oral contraceptive use and risk of benign breast disease.
Rohan TE; Miller AB
Int J Cancer; 1999 Jul; 82(2):191-6. PubMed ID: 10389751
[TBL] [Abstract][Full Text] [Related]
10. Hormonal and reproductive factors and risk of postmenopausal thyroid cancer in the NIH-AARP Diet and Health Study.
Schonfeld SJ; Ron E; Kitahara CM; Brenner A; Park Y; Sigurdson AJ; Schatzkin A; Berrington de González A
Cancer Epidemiol; 2011 Dec; 35(6):e85-90. PubMed ID: 21852218
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of 2 breast cancer risk models in a benign breast disease cohort.
Frank RD; Winham SJ; Vierkant RA; Frost MH; Radisky DC; Ghosh K; Brandt KR; Sherman ME; Visscher DW; Hartmann LC; Degnim AC; Vachon CM
Cancer; 2018 Aug; 124(16):3319-3328. PubMed ID: 29932456
[TBL] [Abstract][Full Text] [Related]
12. Dietary fat, fat subtypes, and breast cancer risk: lack of an association among postmenopausal women with no history of benign breast disease.
Byrne C; Rockett H; Holmes MD
Cancer Epidemiol Biomarkers Prev; 2002 Mar; 11(3):261-5. PubMed ID: 11895875
[TBL] [Abstract][Full Text] [Related]
13. Alcohol consumption and incidence of benign breast disease.
Byrne C; Webb PM; Jacobs TW; Peiro G; Schnitt SJ; Connolly JL; Willett WC; Colditz GA
Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1369-74. PubMed ID: 12433713
[TBL] [Abstract][Full Text] [Related]
14. Lower-category benign breast disease and the risk of invasive breast cancer.
Wang J; Costantino JP; Tan-Chiu E; Wickerham DL; Paik S; Wolmark N
J Natl Cancer Inst; 2004 Apr; 96(8):616-20. PubMed ID: 15100339
[TBL] [Abstract][Full Text] [Related]
15. The influence of family history on breast cancer risk in women with biopsy-confirmed benign breast disease: results from the Nurses' Health Study.
Collins LC; Baer HJ; Tamimi RM; Connolly JL; Colditz GA; Schnitt SJ
Cancer; 2006 Sep; 107(6):1240-7. PubMed ID: 16902983
[TBL] [Abstract][Full Text] [Related]
16. Benign breast biopsy diagnosis and subsequent risk of breast cancer.
Ashbeck EL; Rosenberg RD; Stauber PM; Key CR
Cancer Epidemiol Biomarkers Prev; 2007 Mar; 16(3):467-72. PubMed ID: 17337650
[TBL] [Abstract][Full Text] [Related]
17. Conjugated equine estrogen and risk of benign proliferative breast disease: a randomized controlled trial.
Rohan TE; Negassa A; Chlebowski RT; Habel L; McTiernan A; Ginsberg M; Wassertheil-Smoller S; Page DL
J Natl Cancer Inst; 2008 Apr; 100(8):563-71. PubMed ID: 18398105
[TBL] [Abstract][Full Text] [Related]
18. Natural history of age-related lobular involution and impact on breast cancer risk.
Radisky DC; Visscher DW; Frank RD; Vierkant RA; Winham S; Stallings-Mann M; Hoskin TL; Nassar A; Vachon CM; Denison LA; Hartmann LC; Frost MH; Degnim AC
Breast Cancer Res Treat; 2016 Feb; 155(3):423-30. PubMed ID: 26846985
[TBL] [Abstract][Full Text] [Related]
19. Breast Cancer Risk and Progressive Histology in Serial Benign Biopsies.
Visscher DW; Frank RD; Carter JM; Vierkant RA; Winham SJ; Heinzen EP; Broderick BT; Denison LA; Allers TM; Johnson JL; Frost MH; Hartmann LC; Degnim AC; Radisky DC
J Natl Cancer Inst; 2017 Oct; 109(10):. PubMed ID: 28376198
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer incidence in a cohort of women with benign breast disease from a multiethnic, primary health care population.
Worsham MJ; Abrams J; Raju U; Kapke A; Lu M; Cheng J; Mott D; Wolman SR
Breast J; 2007; 13(2):115-21. PubMed ID: 17319851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
